Is inflammation on papanicolaou smear a risk factor for preterm delivery?

Fetal Diagnosis and Therapy

Volumn 12, Issue 4, 1997, Pages 244-247

  Lanouette, Jan M ^a   Puder, Karoline S ^a   Berry, Stanley M ^a   Bryant, David R ^a   Dombrowski, Mitchell P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial vaginosis; Metronidazole; Papanicolaou smear; Preterm birth

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; METRONIDAZOLE;

ADULT; ARTICLE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MATERNAL AGE; PAPANICOLAOU TEST; PARITY; PREMATURE LABOR; PRIORITY JOURNAL; RACE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; VAGINITIS;

EID: 0030884283     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000264477     Document Type: Article

References (15)

1. Committee to Study the Prevention of Low Birthweight, Division of Health Promotion and Disease Prevention, Institute of Medicine: Preventing Low Birthweight. Washington, National Academy Press, 1985. p 1.
2. Lockwood CJ: Recent advances in elucidating the pathogenesis of preterm delivery, the detection of patients at risk, and preventative therapies. CurrOpin Obstet Gynecol 1994;6:7-18.
3. Gravett MG, Hummel D, Eschcnbach DA, Holmes KK: Preterm labor associated with subclinical amniotic fluid infection with bacterial vaginosis. Obstet Gynecol 1986:67:229-237.
4. Minkoff H, Grunebaum AN, Schwarz RH: Risk factors for prematurity and premature rupture of membranes: A prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984;150:965-972.
5. Alger LS, Lovchik JC, Hebel JR, Blackmon LR, Crenshaw MC: The association if Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstet Gynecol 1988;159:297-404.
6. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edcl-man R. Pastorek JG, Rao V, McNellis D, Regan JA, Carey JC, Kelbanoff MA: Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995;333:1737-1742.
7. McGregor JA, French JI, Parker R: Prevention of premature birth by screening and treatment for common genital tract infections: Results of a prospective controlled evaluation. Am J Obstet Gynecol 1995;173:157-167.
8. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL: A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992;166:1515-1528.
9. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G: Safety of metronidazole in pregnancy: A meta-analysis. Am J Obstet Gynecol 1995;172:525-529.
10. Morales WJ, Schorr S, Albritton J: Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: A placebo-controlled, double-blind study. Am J Obstet Gynecol 1994;171:345-349.
11. Hauth JC, Goldenberg RL, Andrews WW, Du-Bard MB, Copper RL: Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333;26:1732-1736.
12. Schnadig VJ, Davie KD, Shafer SK, Yandell RB, Islam MZ, Hannigan EV: The cytologist and bacterioses of the vaginal-cctocervical area. Acta Cytol 1989;33:287-297.
13. Paavonen J, Critchlow CW, DeRouen T: Etiology of cervical inflammation. Am J Obstet Gynecol 1986;154:556-564.
14. Meis PJ, Goldenberg RL, Mercer B: The preterm prediction study: Significance of vaginal infections. Am J Obstet Gynecol 1995,173: 1231-1235.
15. Cox SM, Bohman VR, Sherman L, Leveno KJ: Randomized investigation of antimicrobials for the prevention of preterm birth. Am J Obstet Gynecol 1996;174:206-210.